Identification of Potential Therapeutic Target Genes in Osteoarthritis

Yang Hu1, Yinteng Wu1, Fu Gan2

  • 1Department of Orthopedics, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.

Abstract

Insights

Three key genes, CX3CR1, MYC, and TLR7, were identified as potential diagnostic markers for osteoarthritis (OA). These genes influence the immune microenvironment and offer therapeutic targets for OA treatment.

Area of Science:

  • Immunology
  • Genetics
  • Bioinformatics

Background:

  • Osteoarthritis (OA) is characterized by joint pain and loss of function.
  • Immune-related genes and immune cell infiltration are critical in OA development.

Purpose of the Study:

  • Identify potential diagnostic markers for OA.
  • Explore the immune mechanisms underlying OA.
  • Discover available drug candidates for OA treatment.

Main Methods:

  • Utilized bioinformatics approaches on Gene Expression Omnibus (GEO) datasets (GSE55235, GSE51588, GSE55457).
  • Identified differentially expressed genes (DEGs) and performed Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA).
  • Analyzed protein-protein interactions (PPI) to identify hub genes (CX3CR1, MYC, TLR7) and their association with immune cells via CIBERSORT and CMAP databases.

Main Results:

  • Identified three hub genes: CX3CR1, MYC, and TLR7.
  • CX3CR1 and TLR7 showed high expression in OA patients, while MYC expression was low.
  • CX3CR1 and TLR7 demonstrated diagnostic potential for OA, and all three genes were linked to the OA immune microenvironment.

Conclusions:

  • CX3CR1, MYC, and TLR7 are associated with immune cells and serve as potential diagnostic markers and therapeutic targets for OA.
  • These genes influence OA's immune response through multiple pathways, offering new avenues for treatment.